Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-02

Clinical Trial Update: Alpha Radiation Emitters Device for the Treatment of Recurrent Lung Cancer [NA]

View source ↗

Summary

A clinical trial is recruiting to evaluate the Alpha Radiation Emitters Device for recurrent lung cancer, sponsored by Alpha Tau Medical Ltd.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alpha Radiation Emitters Device

Snippet

Sponsor: Alpha Tau Medical LTD. | Conditions: Recurrent Lung Cancer, Lung Cancer | NA | Status: RECRUITING